Skip to main content
. Author manuscript; available in PMC: 2024 Nov 1.
Published in final edited form as: Am J Gastroenterol. 2023 Jul 7;118(11):1927–1930. doi: 10.14309/ajg.0000000000002403

Table 2.

Detection rates and unadjusted risks and adjusted hazard ratios for post colonoscopy colorectal cancer (PCCRC) in patients with* and without# follow up event

Sessile serrated lesion Detection Rate (SSLDR) (with at least 1 follow up event)* (n=26,901)
< 1.0 1.0 – < 2.0 2.0 – < 4.0 4.0 – < 6.0 6.0+
Unadjusted risk PCCRC % 1.4% 0.6% 0.6% 0.4% 0.3%*
N 58/4117 46/8075 22/3950 18/4011 18/6748
***Adjusted Hazard HR 1.0 0.41 0.45 0.38 0.29
95% CI Reference 0.28–0.61 0.27–0.75 0.22–0.66 0.16–0.50
Sessile serrated lesion Detection Rate (SSLDR) (with/without follow up event)**(n= 114,197)
< 1.0 1.0 – < 2.0 2.0 – < 4.0 4.0 – < 6.0 6.0+
Unadjusted risk PCCRC % 0.31% 0.18% 0.11% 0.09% 0.06%*
N 58/18793 46/25824 22/19693 18/19518 18/30369
***Adjusted Hazard HR 1.0 0.46 0.53 0.49 0.36
95% CI Reference 0.31–0.68 032–0.88 0.29–0.85 0.21–0.62
*

p < 0.0001

***

Cox regression was used to model the hazard of PCCRC on SSLDR controlling for age, sex, presence of CSSPs, presence of advanced adenomas, year of index exam, indication of index exam, bowel prep quality, and having more than 1 surveillance exam.

**

Censored at 1st follow up or 6 months prior to last linkage date with the NH State Cancer Registry